1. Archer, T. (1989) “Neurotoxin-induced cognitive and motor activity modifications: a catecholamine connection”, In: Sagvolden, T. and Archer, T., eds, Attention Deficit Disorder: Clinical and Basic Research (Lawrence Earlbaum Associates, Hillsdale, NJ), pp 287–322.
2. Archer, T. and Fredriksson, A. (1992) “Functional changes implicating dopaminergic systems following perinatal treatments”, Dev. Pharmacol. Ther. 18, 201–222.
3. Archer, T. and Fredriksson, A. (2000) “Effects of α-adrenoceptor agonists in chronic morphine administered DSP4-treated rats: evidence for functional cross-sensitization”, Neurotoxicty Res. 2, 1–22.
4. Archer, T., Jonsson, G. and Ross, S.B. (1984) “A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurons in the CNS of the rat”, Br. J. Pharmacol. 82, 249–257.
5. Archer, T. and Mohammed, A.K. (1989) “Neurochemistry and behaviour: differential postweaning housing and catecholamines”, In: Blanchard, R.J., Brain, P.F., Blanchard, D.C. and Parmigiani, S., eds, Ethoexperimental Approaches to the Study of Behaviour (Kluwer Academic Publishers, Dordrecht), pp 241–252.